AR023045A2 - COMPOSITION OF DRIED TIOTEPA BY FREEZING FOR PARENTERAL ADMINISTRATION - Google Patents
COMPOSITION OF DRIED TIOTEPA BY FREEZING FOR PARENTERAL ADMINISTRATIONInfo
- Publication number
- AR023045A2 AR023045A2 ARP990104393A ARP990104393A AR023045A2 AR 023045 A2 AR023045 A2 AR 023045A2 AR P990104393 A ARP990104393 A AR P990104393A AR P990104393 A ARP990104393 A AR P990104393A AR 023045 A2 AR023045 A2 AR 023045A2
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- tiotepa
- freezing
- dried
- parenteral administration
- Prior art date
Links
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 title abstract 2
- 230000008014 freezing Effects 0.000 title 1
- 238000007710 freezing Methods 0.000 title 1
- 238000007911 parenteral administration Methods 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003113 alkalizing effect Effects 0.000 abstract 1
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960001196 thiotepa Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composicion liofilizada estable del agente alquilante antitumoral tiotepa y un método para preparar dicha composicion a través de la co-liofilizaciondel ingrediente activo con un agente alcalinizante farmacéuticamente aceptableA stable lyophilized composition of the thiotepa antitumor alkylating agent and a method for preparing said composition through co-lyophilization of the active ingredient with a pharmaceutically acceptable alkalizing agent
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15050193A | 1993-11-09 | 1993-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR023045A2 true AR023045A2 (en) | 2002-09-04 |
Family
ID=22534834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990104393A AR023045A2 (en) | 1993-11-09 | 1999-09-01 | COMPOSITION OF DRIED TIOTEPA BY FREEZING FOR PARENTERAL ADMINISTRATION |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5561121A (en) |
| EP (1) | EP0656211B1 (en) |
| JP (1) | JP3726255B2 (en) |
| KR (1) | KR100348382B1 (en) |
| CN (1) | CN1111130A (en) |
| AR (1) | AR023045A2 (en) |
| AT (1) | ATE180670T1 (en) |
| AU (1) | AU690143B2 (en) |
| CA (1) | CA2135265A1 (en) |
| CZ (1) | CZ287052B6 (en) |
| DE (1) | DE69418832T2 (en) |
| DK (1) | DK0656211T3 (en) |
| ES (1) | ES2133152T3 (en) |
| FI (1) | FI116036B (en) |
| GR (1) | GR3031122T3 (en) |
| HU (1) | HU218216B (en) |
| IL (1) | IL111534A (en) |
| NO (1) | NO305274B1 (en) |
| NZ (1) | NZ264861A (en) |
| PE (1) | PE22995A1 (en) |
| PH (1) | PH31219A (en) |
| PL (1) | PL176984B1 (en) |
| RU (1) | RU2134112C1 (en) |
| SG (1) | SG63584A1 (en) |
| SI (1) | SI0656211T1 (en) |
| SK (1) | SK280840B6 (en) |
| TW (1) | TW344662B (en) |
| ZA (1) | ZA948833B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9726343D0 (en) * | 1997-12-13 | 1998-02-11 | Auffret Anthony | The use of excipients to accelerate freeze-drying |
| JP2004532277A (en) * | 2001-06-08 | 2004-10-21 | パウダージェクト ワクチンズ，インコーポレーテッド | Spray freeze-dried composition |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| AR072777A1 (en) | 2008-03-26 | 2010-09-22 | Cephalon Inc | SOLID FORMS OF BENDAMUSTINE CHLORHYDRATE |
| CA2735899A1 (en) | 2008-09-25 | 2010-04-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
| CN102281877B (en) | 2009-01-15 | 2014-07-23 | 赛福伦公司 | The free base form of bendamustine |
| KR20140082736A (en) * | 2011-09-29 | 2014-07-02 | 얀센 파마슈티카 엔.브이. | Process for the preparation of sulfamide derivatives |
| CN104349417B (en) * | 2013-08-07 | 2017-11-21 | 中国科学院声学研究所 | The network-building method of regional submarine communication network based on short life cycle |
| WO2018227112A1 (en) | 2017-06-09 | 2018-12-13 | The Trustees Of Columbia University In The City Of New York | Short tat oligomers for drug delivery |
| CN109956972A (en) * | 2017-12-22 | 2019-07-02 | 四川科瑞德凯华制药有限公司 | Seltepa crystal form I and its preparation method and use |
| CN110917146A (en) * | 2019-12-03 | 2020-03-27 | 黑龙江福和制药集团股份有限公司 | Thiotepa powder injection and preparation method thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2670347A (en) * | 1952-01-08 | 1954-02-23 | American Cyanamid Co | Thiophosphoric acid derivatives and method of preparing the same |
| GB845823A (en) * | 1957-09-19 | 1960-08-24 | Sumitomo Chemical Co | Stabilised compositions comprising therapeutic imine derivatives and the preparation thereof |
| DE1951822C3 (en) * | 1969-10-14 | 1980-12-11 | Kowa Co., Ltd., Nagoya, Aichi (Japan) | Pharmaceutical preparation for the treatment of cancer |
| DE2925009A1 (en) * | 1979-06-21 | 1981-01-08 | Basf Ag | PREPARATION FOR SUBSTANCES, METHOD FOR THE PRODUCTION AND USE THEREOF |
| EP0120907A1 (en) * | 1982-10-13 | 1984-10-10 | Aston Molecules Limited | Pharmaceutical preparations for use in antitumour therapy |
| DE3484584D1 (en) * | 1983-10-14 | 1991-06-20 | Sumitomo Pharma | INJECTIONS WITH DELAYED DELIVERY. |
| CH676508A5 (en) * | 1986-10-13 | 1991-01-31 | Anawa Lab Ag | |
| US4918199A (en) * | 1988-01-21 | 1990-04-17 | American Cyanamid Company | Process for producing thiotepa |
| US5122367A (en) * | 1989-03-31 | 1992-06-16 | Massachusetts Institute Of Technology | Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone |
| EP0419890A3 (en) * | 1989-09-29 | 1991-05-29 | American Cyanamid Company | Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method |
-
1994
- 1994-08-02 US US08/284,336 patent/US5561121A/en not_active Expired - Lifetime
- 1994-11-04 CZ CZ19942718A patent/CZ287052B6/en not_active IP Right Cessation
- 1994-11-04 JP JP29362694A patent/JP3726255B2/en not_active Expired - Fee Related
- 1994-11-04 RU RU94040150A patent/RU2134112C1/en not_active IP Right Cessation
- 1994-11-04 NZ NZ264861A patent/NZ264861A/en not_active IP Right Cessation
- 1994-11-06 IL IL11153494A patent/IL111534A/en not_active IP Right Cessation
- 1994-11-07 CA CA002135265A patent/CA2135265A1/en not_active Abandoned
- 1994-11-07 PE PE1994254198A patent/PE22995A1/en not_active Application Discontinuation
- 1994-11-08 ZA ZA948833A patent/ZA948833B/en unknown
- 1994-11-08 PH PH49332A patent/PH31219A/en unknown
- 1994-11-08 HU HU9403210A patent/HU218216B/en not_active IP Right Cessation
- 1994-11-08 NO NO944256A patent/NO305274B1/en unknown
- 1994-11-08 FI FI945252A patent/FI116036B/en not_active IP Right Cessation
- 1994-11-08 KR KR1019940029169A patent/KR100348382B1/en not_active Expired - Fee Related
- 1994-11-08 AU AU77689/94A patent/AU690143B2/en not_active Expired
- 1994-11-08 PL PL94305752A patent/PL176984B1/en not_active IP Right Cessation
- 1994-11-09 DE DE69418832T patent/DE69418832T2/en not_active Expired - Fee Related
- 1994-11-09 SI SI9430237T patent/SI0656211T1/en unknown
- 1994-11-09 AT AT94117666T patent/ATE180670T1/en not_active IP Right Cessation
- 1994-11-09 EP EP94117666A patent/EP0656211B1/en not_active Expired - Lifetime
- 1994-11-09 SG SG1996003935A patent/SG63584A1/en unknown
- 1994-11-09 ES ES94117666T patent/ES2133152T3/en not_active Expired - Lifetime
- 1994-11-09 DK DK94117666T patent/DK0656211T3/en active
- 1994-11-09 SK SK1352-94A patent/SK280840B6/en unknown
- 1994-11-09 CN CN94118057A patent/CN1111130A/en active Pending
- 1994-12-24 TW TW083112146A patent/TW344662B/en active
-
1999
- 1999-08-31 GR GR990402204T patent/GR3031122T3/en unknown
- 1999-09-01 AR ARP990104393A patent/AR023045A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR002355A1 (en) | COMPOSITIONS AND METHODS FOR LOCAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS. | |
| AR023045A2 (en) | COMPOSITION OF DRIED TIOTEPA BY FREEZING FOR PARENTERAL ADMINISTRATION | |
| CO4290346A1 (en) | Azithromycin Controlled Release Dosage Forms | |
| PL335571A1 (en) | Stabilisation of acid-sensitive benzimidazoles by combining them with amino acids and cyclodextrins | |
| MY129356A (en) | Electrospun pharmaceutical compositions | |
| TR199501599A2 (en) | Intravaginal drug administration devices for the delivery of 17-oestradiol precursor | |
| MY100721A (en) | Therapeutic agent. | |
| ES2096103T3 (en) | PREPARATION OF INCREASED RESISTANCE TABLETS. | |
| GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
| BR9604880A (en) | Compound composition dosage unit form methods for administering a biologically active agent for preparing a composition for administering an active agent and for preparing a compound and pharmacological composition | |
| ES2039480T3 (en) | A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE. | |
| ES2009251A6 (en) | A METHOD OF OBTAINING A CONTRACEPTIVE COMPOSITION FOR WOMEN | |
| ES2081531T3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE FOR THE TREATMENT OF VAGINAL INFECTIONS. | |
| AR017979A1 (en) | PHARMACEUTICAL FORMULATIONS OF EPOTILONES, METHOD FOR THE PREPARATION AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| AR013117A1 (en) | A SOLID PHARMACEUTICAL COMPOSITION IN THE FORM OF A TABLET THAT INCLUDES A BENZOFURAN DERIVATIVE WITH ANTIARRHYTHMIC ACTIVITY ADAPTED FOR ORAL ADMINISTRATION | |
| EP0830369A4 (en) | Novel nor-pregnanes for inducing hypothalamic effects | |
| CO4900022A1 (en) | TOPIC COMPOSITION AND METHOD TO INCREASE THE SYNTHESIS OF THE LIPID BARRIER THE LIPID BARRIER USING SUCH COMPOSITION | |
| MY113203A (en) | Lyophilizate of lipid complex of water insoluble camptothecins | |
| AR019699A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DYSFUNCTION OF THE EVACUATION AND USE OF THE SAME FOR THE PREPARATION OF A THERAPEUTIC AGENT | |
| GEP20043162B (en) | Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance | |
| MY124465A (en) | Reduction of infarct volume using citicoline | |
| AR002191A1 (en) | ORAL PHARMACEUTICAL COMPOSITION OF PIPERIDINOALCANOL COMPOUNDS IN THE FORM OF SOLUTION, PROCEDURE FOR ITS PREPARATION | |
| HRP20020258B1 (en) | PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR USE AS CONTRACEPTIVE | |
| ES2181915T3 (en) | CTLA-8 IN COMBINATION WITH G-CSF AND IL-6, AND USE OF CTLA-8 TO TREAT INFECTIONS. | |
| ES2194899T3 (en) | PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION OF THE MORFINA-6-GLUCURONIDO ACTIVE PRINCIPLE. |